Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Thomas Gaziano MD, MSc

Thomas A. Gaziano MD, MSc

Director, Global Cardiovascular Health Policy and Prevention Unit Cardiovascular Medicine Division, Brigham & Women's Hospital: Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Thomas A. Gaziano, M.D., M.Sc., is an Assistant Professor of Medicine at Harvard Medical School and an Associate Physician in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital (BWH). Dr. Thomas Gaziano graduated from Oxford University, where he was a Rhodes Scholar, Harvard Medical School and Harvard TH Chan School of Public Health. He completed residency and fellowship training in Internal Medicine and Cardiovascular Disease respectively at the Brigham and Women’s Hospital and received the Eugene Braunwald Fellowship for research.

He is the Director of the Global Health Policy and Prevention Unit within the Cardiovascular Division at BWH where he integrates his research and clinical activities to develop innovative prevention programs in clinical services. He serves as Clinical Director of the iHeart Champion Program that is a navigator run remote CVD risk reduction initiative to lower blood pressure and LDL cholesterol among a commercially insured population. He also holds a secondary appointment at the Harvard TH Chan School of Public Health where he works at the Center for Health Decision Science. The focus of his work at the Center is the application of his CVD PREDICT model to evaluate health outcomes, financial impacts, and the cost-effectiveness of CVD prevention and intervention strategies.

Dr. Gaziano is a Fellow of the American College of Cardiology (ACC) and is an elected Board Member of The World Heart Federation (WHF). He served as a co-editor of the Cardiovascular and Metabolic Volume of the Disease Control Priorities Project in Developing Countries supported by the Gates Foundation. His current work funded by the National Institutes of Health includes seeking innovations in risk assessment and management strategies in the United States, South Africa, Argentina and other low and middle-income countries. He served as Co-Principle Investigator of the NHLBI funded Center of Excellence for Chronic Diseases in Southern Africa – a joint effort between BWH/HMS and the Department of Medicine, University of Cape Town where he also has held an Honorary Senior Lectureship. He has authored over 100 peer reviewed journal articles and textbook chapters.


Dr. Gaziano reports no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Cost-Effectiveness of Alirocumab